InMed Pharmaceuticals Inc. (INM) Financials
INM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 11.5 million | 1.9 million |
| 2023-09-30 | 8.0 million | 985430 |
| 2023-06-30 | 10.7 million | 1.5 million |
| 2023-03-31 | 10.9 million | 1.7 million |
INM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.4 million | 13770 |
| 2023-09-30 | -1.6 million | 18535 |
| 2023-06-30 | -522388 | 30578 |
| 2023-03-31 | -1.3 million | 37221 |
INM Net Income
No data available :(
INM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 7.2 million | - | 879838 |
| 2023-09-30 | 5.0 million | - | 215590 |
| 2023-06-30 | 6.7 million | - | 295895 |
| 2023-03-31 | 7.1 million | - | 366888 |
INM Shares Outstanding
INM Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 6950 | 459751 | 1.0 million | - |
| 2023-09-30 | - | 950732 | 955616 | - |
| 2023-06-30 | 25385 | 471175 | 1.1 million | - |
| 2023-03-31 | 94757 | 649194 | 1.0 million | - |
INM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 935047 | 690660 |
| 2023-09-30 | 1.2 million | 1.2 million |
| 2023-06-30 | 1.7 million | 559513 |
| 2023-03-31 | 764221 | 621928 |
INM
Price: $0.24
52 week price:
Earnings Per Share: -0.42 USD
P/E Ratio: 6.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 53653
Market Capitalization: 2.0 million